Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases-Reference-Cited by-同舟云学术

Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases

Published:2018-01-01 Issue:1 Volume:22 Page:34-39
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Payen M. C.¹,Muylle I.²,Vandenberg O.³,Mathys V.⁴,Delforge M.¹,Van den Wijngaert S.³,Clumeck N.¹,De Wit S.¹

Affiliation:

1. Infectious Diseases

2. Pneumology, Centre Hôspitalier Universitaire Saint-Pierre. Université Libre de Bruxelles, Brussels

3. Laboratoire Hospitalier Universitaire de Bruxelles, Department of Microbiology, Pôle Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels

4. Bacterial Diseases Service, Operational Direction Communicable and Infectious Diseases, Scientific Institute of Public Health, Brussels, Belgium

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LdtC Is a Key l , d -Transpeptidase for Peptidoglycan Assembly in Mycobacterium smegmatis;Journal of Bacteriology;2023-01-26

2. Tuberkulose im Erwachsenenalter;Pneumologie;2022-11

3. Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium tuberculosis;Antimicrobial Agents and Chemotherapy;2022-09-20

4. Prospects for Expanding Drug Therapy for Multiple Drug Resistant and Extensively Drug Resistant Tuberculosis;Tuberculosis and Lung Diseases;2022-04-06

5. Beta-lactam antibiotics as reserve medications for the treatment of drug-resistant tuberculosis;Antibiotics and Chemotherapy;2021-08-30